Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
18.91
+0.25 (1.34%)
At close: Nov 26, 2025, 4:00 PM EST
18.95
+0.04 (0.21%)
After-hours: Nov 26, 2025, 7:54 PM EST
Baxter International Revenue
Baxter International had revenue of $2.84B in the quarter ending September 30, 2025, with 5.04% growth. This brings the company's revenue in the last twelve months to $11.02B, up 3.90% year-over-year. In the year 2024, Baxter International had annual revenue of $10.64B with 2.66% growth.
Revenue (ttm)
$11.02B
Revenue Growth
+3.90%
P/S Ratio
0.88
Revenue / Employee
$290,079
Employees
38,000
Market Cap
9.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.64B | 276.00M | 2.66% |
| Dec 31, 2023 | 10.36B | 303.00M | 3.01% |
| Dec 31, 2022 | 10.06B | -2.09B | -17.20% |
| Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
| Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BAX News
- 3 days ago - Artisan Value Income Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 3 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Newsfile Corp
- 6 days ago - UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - PRNewsWire
- 6 days ago - BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - GlobeNewsWire
- 7 days ago - Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027 - Business Wire
- 8 days ago - Baxter Announces Tender Offers for 2026 Notes and 2027 Notes - Business Wire
- 9 days ago - Baxter International Inc. (BAX) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 15 days ago - Greenhaven Bets Over $143 Million on a Turnaround at Medical Devices Leader Baxter - The Motley Fool